TRIMTECH Therapeutics
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
$47MSeed+
Role not disclosedLoading investors…
Activity from announced rounds
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
Provides AI-native security agents for autonomous systems
Provides a generative physics AI model for engineering teams
Pitching Cambridge Innovation Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room